APOE and cardiovascular disorder: In the Marmontel 2023 study, the lipid levels and the frequency of premature atherosclerotic cardiovascular diseases were compared between the LDLR + APOE carriers (n = 21) and the carriers of the same LDLR causative variants alone (n = 22) [40].